StayBred requires FDA approval or ANDA filing
Company: Riot
The claim, verbatim
FDA approval is required prior to sale of StayBred unless sold through compounding pharmacies after ANDA filing
Source (primary)
Riot SB-2 filed 2004-09-14 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “FDA approval is required prior to the sale of StayBred unless it is sold thru compounding pharmacies after an ANDA has been filed.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Riot SB-2 filed 2004-09-14
Quote: “FDA approval is required prior to the sale of StayBred unless it is sold thru compounding pharmacies after an ANDA has been filed.”